Aucune différence dans le risque de thrombopénie au cours du traitement de l'embolie pulmonaire et de thrombose veineuse profonde avec soit faible poids moléculaire ou héparine héparine non fractionnée: une méta-analyse

Catégorie Structured summary of systematic reviews
JournalDatabase of Abstracts of Reviews of Effects (DARE)
Year 2008
Loading references information

CRD SUMMARY:

This was a generally well-conducted meta-analysis exploring the risk of thrombocytopenia in patients prescribed low-molecular-weight heparin or unfractionated heparin for venous thromboembolism. The authors performed a thorough quality assessment of the included studies and used appropriate statistical methods to combine the data. The conclusions seem reliable based on the evidence presented.
Epistemonikos ID: d8b15ca7525748607fa93bdf5d4bb045030c8244
First added on: Jun 07, 2012